Cargando…

Improved Mitochondrial Function Underlies the Protective Effect of Pirfenidone against Tubulointerstitial Fibrosis in 5/6 Nephrectomized Rats

Dysfunctional mitochondria participate in the progression of chronic kidney disease (CKD). Pirfenidone is a newly identified anti-fibrotic drug. However, its mechanism remains unclear. Mitochondrial dysfunction is an early event that occurs prior to the onset of renal fibrosis. In this context, we i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jun-Feng, Liu, Hong, Ni, Hai-Feng, Lv, Lin-Li, Zhang, Ming-Hui, Zhang, Ai-Hua, Tang, Ri-Ning, Chen, Ping-Sheng, Liu, Bi-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857290/ https://www.ncbi.nlm.nih.gov/pubmed/24349535 http://dx.doi.org/10.1371/journal.pone.0083593

Ejemplares similares

Rhubarb Enema Attenuates Renal Tubulointerstitial Fibrosis in 5/6 Nephrectomized Rats by Alleviating Indoxyl Sulfate Overload
por: Lu, Zhaoyu, et al.
Publicado: (2015)

Pioglitazone Improves Mitochondrial Function in the Remnant Kidney and Protects against Renal Fibrosis in 5/6 Nephrectomized Rats
por: Sun, Li, et al.
Publicado: (2017)

Protective efficacy of pirfenidone in rats with pulmonary fibrosis induced by bleomycin
por: Demirkol, Barış, et al.
Publicado: (2023)

Is the proximal tubule the focus of tubulointerstitial fibrosis?
por: Peng, Zhi, et al.
Publicado: (2023)

DsbA-L mediated renal tubulointerstitial fibrosis in UUO mice
por: Li, Xiaozhou, et al.
Publicado: (2020)

Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011)

Role of pirfenidone in the management of pulmonary fibrosis
por: Meyer, Keith C, et al.
Publicado: (2017)

Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
por: Aimo, Alberto, et al.
Publicado: (2022)

Rhubarb Protect Against Tubulointerstitial Fibrosis by Inhibiting TGF-β/Smad Pathway and Improving Abnormal Metabolome in Chronic Kidney Disease
por: Zhang, Zhi-Hao, et al.
Publicado: (2018)

Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis
por: Chen, Lin, et al.
Publicado: (2019)

The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent
Publicado: (2013)

Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
por: Takeda, Yoshito, et al.
Publicado: (2014)

Dietary tetrahydrocurcumin reduces renal fibrosis and cardiac hypertrophy in 5/6 nephrectomized rats
por: Lau, Wei Ling, et al.
Publicado: (2018)

Mesoporous Polydopamine Loaded Pirfenidone Target to Fibroblast Activation Protein for Pulmonary Fibrosis Therapy
por: Fang, Qi, et al.
Publicado: (2022)

The Protective Effect of Zebularine, an Inhibitor of DNA Methyltransferase, on Renal Tubulointerstitial Inflammation and Fibrosis
por: Koh, Eun Sil, et al.
Publicado: (2022)

Protein arginine methyltransferase 3 inhibits renal tubulointerstitial fibrosis through asymmetric dimethylarginine
por: Wang, Yanzhe, et al.
Publicado: (2022)

TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
por: Yu, Xiao-Yong, et al.
Publicado: (2022)

Repurposing of Pirfenidone (Anti-Pulmonary Fibrosis Drug) for Treatment of Rheumatoid Arthritis
por: Gan, Donghao, et al.
Publicado: (2021)

Polydatin attenuates tubulointerstitial fibrosis in diabetic kidney disease by inhibiting YAP expression and nuclear translocation
por: He, Manlin, et al.
Publicado: (2022)

Effect of 5/6 Nephrectomized Rat Serum on Epithelial-to-Mesenchymal Transition In Vitro
por: Lu, Zhaoyu, et al.
Publicado: (2011)

Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys
por: Xu, Lin, et al.
Publicado: (2021)

Case Report: Pirfenidone in the Treatment of Post-COVID-19 Pulmonary Fibrosis
por: Zhou, Xianglin, et al.
Publicado: (2022)

Knockout of NGAL aggravates tubulointerstitial injury in a mouse model of diabetic nephropathy by enhancing oxidative stress and fibrosis
por: Liu, Xiaoli, et al.
Publicado: (2021)

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2017)

Could Pirfenidone Also be Effective in Treating Intestinal Fibrosis?
por: Latella, Giovanni, et al.
Publicado: (2020)

Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis
por: Glassberg, Marilyn K., et al.
Publicado: (2019)

THE EFFECTS OF SUBMINIMUM DOSES OF STRYCHNINE IN NEPHRECTOMIZED RABBITS
por: Meltzer, S. J., et al.
Publicado: (1902)

Effect of pirfenidone protecting against cigarette smoke extract induced apoptosis
por: Ma, Yiming, et al.
Publicado: (2022)

Asiatic acid ameliorates tubulointerstitial fibrosis in mice with ureteral obstruction
por: XU, CHANGGENG, et al.
Publicado: (2013)

Inhibition of TGF-β2–Induced Trabecular Meshwork Fibrosis by Pirfenidone
por: Zhu, Xiaofeng, et al.
Publicado: (2023)

Real world experience on the effectiveness and safety of pirfenidone in patients with idiopathic pulmonary fibrosis in Taiwan
por: Chang, Cheng-Yu, et al.
Publicado: (2023)

Analysis of the safety and efficacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary fibrosis
por: Li, Hui, et al.
Publicado: (2022)

Inflammatory Stress Exacerbates the Progression of Cardiac Fibrosis in High-Fat-Fed Apolipoprotein E Knockout Mice via Endothelial-Mesenchymal Transition
por: Ma, Kun Ling, et al.
Publicado: (2013)

Qingshen Buyang Formula Attenuates Renal Fibrosis in 5/6 Nephrectomized Rats via Inhibiting EMT and Wnt/β-Catenin Pathway
por: Zhang, Xueqin, et al.
Publicado: (2019)

Pirfenidone as a novel cardiac protective treatment
por: Aimo, Alberto, et al.
Publicado: (2021)

Mefunidone Attenuates Tubulointerstitial Fibrosis in a Rat Model of Unilateral Ureteral Obstruction
por: Liu, Chunyan, et al.
Publicado: (2015)

Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis
por: Zhang, Zhi-Hao, et al.
Publicado: (2015)

Plk1 promotes renal tubulointerstitial fibrosis by targeting autophagy/lysosome axis
por: Du, Yang, et al.
Publicado: (2023)

Pirfenidone treatment in idiopathic pulmonary fibrosis: A Saudi experience
por: Alhamad, Esam H.
Publicado: (2015)

Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
por: Salih, Goran Nadir, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uau0c1f12ceig7sbjct6k7svok